B+
Bull case
25%
Probability
Target price
$2.40
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
LUNG
PulmonxFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The best post-print bull read would be confirmation that first-quarter demand did not deteriorate versus the March setup, especially if management can keep 2026 revenue guidance intact while showing operating-expense discipline and no sharper-than-planned cash burn.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
2026 revenue guidance of $90 million-$92 million is only around flat with 2025 revenue of $90.5 million, which is a modest setup for a company that still needs adoption-driven growth to escape balance-sheet scrutiny.
Momentum
82
Value
37
Sentiment
15
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.00 · Bull $2.40 · Bear $0.50Analysis 2026-04-29; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $3.40
Why
Momentum82 · Δ7d -
Value37 · Δ7d -0.0
Sentiment15 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • 2026 revenue guidance of $90 million-$92 million is only around flat with 2025 revenue of $90.5 million, which is a modest setup for a company that still needs adoption-driven growth to escape balance-sheet scrutiny.
- • As of April 29, 2026, the checked company IR and SEC-filings pages did not yet show the Q1 2026 earnings release or a new earnings 8-K, so the key surprise/guidance datapoint for this follow-up run is still missing.
- • The bear read is that the March 2026 reset already implied a low bar, yet 2026 guidance was roughly flat to 2025 revenue and still called for meaningful cash use; any Q1 miss, weaker U.S.
Catalyst clock
2026-04-29
Q1 2026 earnings release is the immediate unresolved swing factor
Lead driver: Value · See fundamentals
Momentum
82
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
15
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 81.6 / Value 36.6 / Sentiment 14.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-29. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1.00
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.50
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$95.78M
Beta
0.08
Shares Out
42.95M
P/E (TTM) · Derived
-1.7
P/S (TTM)
1.01
P/FCF (TTM) · Derived
-2.98
Rev YoY
-4.6%
EPS YoY
-36.7%
Gross Margin
+76.7%
Op Margin
-53.0%
Net Debt
-$13.65M
Current Ratio
4.32
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data